[Estrogenicity of trans-resveratrol in immature mice in vivo].
To investigate the estrogenicity of trans-resveratrol in vivo, different doses of trans-resveratrol were administered orally (ig.) or subcutaneously (s.c.) to the weanling mice for 4 d. The results showed that 2.0 mg/kg.b.w of trans-transveratrol (ig or s.c.) could shorten vaginal opening latency periods (P < 0.05) and enhance keratinization of vaginal epithelium dramatically, increase uterine wet weights and uterine-body weight ratios significantly (P < 0.05, P < 0.01). Additionally, trans-transveratrol could thicken the columnar epithelial cells or increase the numbers of glands in uterine in immature mice. It was concluded that trans-transveratrol could appear estrogenic actions in vivo. Moreover, its activity via subcutaneous administration was higher than that via oral administration.